Bond.az White LogoBond.az Black Logo

Trio-Tech Director Sells $818,325 in Shares

Trio-Tech International director Jason Adelman sold 50,000 shares for $818,325. Stock surged 424% over the past year but appears overvalued.

Chloe Hall
ByChloe Hall- Senior Editor
|
0

Jason T. Adelman, a director at Trio-Tech International (NASDAQ:TRT), recently sold a total of 50,000 common shares for approximately $818,325. The transactions occurred on May 18 and May 19, 2026.

Adelman acquired 39,750 shares on May 18 at $2.25 per share via option exercise. He then sold 35,000 shares at prices ranging from $14.87 to $18.76 on May 18, and another 14,975 shares at $13.97 to $14.01 on May 19.

TRT shares surged 424% over the past year, with a P/E ratio of 370.55. Bond.az analysis indicates the stock is overvalued based on Fair Value calculations.

After the sales, Adelman directly holds 40,000 shares. The transactions were disclosed in a Form 4 filing with the SEC on May 20, 2026.

In other news, Trio-Tech reported a 124% revenue increase to $16.5 million in its fiscal third quarter. The company also completed a $10 million stock offering and suffered a ransomware attack at its Singapore subsidiary.

More News
Today / 17:02
|
888

Blue Bird director Daniel Thau buys $19,527 of BLBD stock

Blue Bird Corp director Daniel Thau buys $19,527 of BLBD stock. Stock up 58% over past year. Read more on Bond.az.

0
Today / 15:34
|
459

AMPCO Pittsburgh CEO buys $29,791 in stock

AMPCO Pittsburgh CEO Brett McBrayer bought $29,791 in company stock. Shares dropped 20% last week but gained 201% over the past year.

0
Today / 15:24
|
946

Farmers & Merchants director sells $241,650 in stock

Farmers & Merchants Bancorp director Andrew J. Briggs sold $241,650 in stock. Dividend increase and other updates.

0
Today / 14:53
|
878

Fossil director buys $100,730 in shares

Fossil Group director Wendy Schoppert buys $100,730 in shares. The company also reported better-than-expected Q1 2026 financial results.

0
Today / 02:13
|
367

Artiva insider sells $63,072 in stock

Artiva Biotherapeutics insider Christopher Horan sells $63,072 in stock. Latest clinical updates and analyst rating included.

0
Today / 02:11
|
275

Artiva Biotherapeutics SVP Sells $27,879 in Stock

Artiva Biotherapeutics SVP Heather Raymon sells $27,879 in stock. Stock down 18.6% this week but up 296% over the year. Insights from Bond.az.

0
Today / 01:40
|
272

Fold Holdings director buys $10,551 in shares

Fold Holdings director buys $10,551 in shares as stock nears 52-week low. Financial results miss expectations.

0
Today / 01:40
|
785

Netlist CFO sells $23,311 in stock

Netlist CFO Gail Sasaki sells $23,311 worth of shares for tax obligations. Stock up 238% in year but down 24% in week.

0
Today / 01:31
|
364

MeiraGTx CEO Forbes Alexandria sells $568,540 in shares

MeiraGTx CEO Forbes Alexandria sells $568,540 in shares. The stock has returned 66% over the past year but faces profitability challenges.

0
Today / 01:30
|
868

Archer Aviation CFO Sells $73,896 in Stock

Archer Aviation Chief Accounting Officer Harsh Rungta sold $73,896 worth of stock. The sale was to cover tax withholding obligations.

0
Today / 01:22
|
374

Outset Medical GC sells $9,760 in shares

Outset Medical General Counsel John Brottem sold $9,760 worth of shares. The stock is down 80% over the past year.

0
Today / 01:21
|
331

FTV entities sell $159.45M in Neptune Insurance stock

FTV-affiliated funds sold over 6 million shares of Neptune Insurance Holdings for approximately $159.45 million. Analysts forecast profitability this year.

0
...